Ginger tea
Combination Productdetermine the optimal dosage of ginger tea that produces significant blood pressure reduction without adverse effects.
NCT Number: NCT06762834
The purpose of this study is to evaluate the antihypertensive effects of ginger tea. By examining its impact on blood pressure levels, this research aims to determine whether ginger tea can be an effective, natural adjunct to conventional hypertension treatments.
This study is active but is not currently recruiting participants.
Notify Me30 year–65 year
All sexes
Interventional
Not applicable
Azra Naheed Medical College, Superior University, Lahore, Punjab Province, Pakistan
This investigation will provide insights into its potential role in reducing the burden of hypertension and improving cardiovascular health
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
determine the optimal dosage of ginger tea that produces significant blood pressure reduction without adverse effects.
To identify consumption and its correlation with blood pressure outcomes using a self- reported diary and periodic clinical assessments.
Time frame: 12 Months
Measure changes in SBP before and after the intervention with ginger tea over a defined period.
Time frame: 12 Months
Measure the total Oxygen Radical Absorbance Capacity (ORAC) value of ginger tea consumed by participants to evaluate its antioxidant capacity and potential correlation with blood pressure changes.
Time frame: 12 months
Measure changes in DBP before and after the intervention with ginger tea over a defined period.
Superior University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05198674
Cardiovascular Diseases, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT07727356
ACTH Syndrome, Ectopic, Adrenal Gland Diseases
Zurich, Switzerland
View Trial DetailsNCT06205628
Cardiovascular Diseases, Essential Hypertension
Adelaide, South Australia, Australia
View Trial DetailsNCT07726394
Cardiovascular Diseases, Hypernatremia
Subang Jaya, Selangor, Malaysia
View Trial Details